Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)

This study has been completed.

Sponsor:

Information provided by:

Chiesi Farmaceutici S.p.A.

ClinicalTrials.gov Identifier:

NCT01343745

First received: April 21, 2011

Last updated: May 6, 2011

Last verified: May 2011

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	August 2008
Primary Completion Date:	August 2008 (Final data collection date for primary outcome measure)

No publications provided by Chiesi Farmaceutici S.p.A.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

O'Connor BJ, Collarini S, Poli G, Brindicci C, Spinola M, Acerbi D, Barnes PJ, Leaker B. Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial. BMC Pulm Med. 2011 Dec 21;11:60.

To Top